Cardiovascular

Fibrin Clot Properties in Aneurysmal Coronary Artery Disease: CARE-ANEURYSM Study.

TL;DR

CAEA is independently associated with unfavorably altered fibrin clot properties, reflected by denser clot structure and reduced susceptibility to fibrinolysis, and oxidative stress may contribute to this modification.

Key Findings

Patients with coronary artery ectasias and aneurysms (CAEA) had a denser fibrin clot structure than matched controls, reflected by lower fibrin clot permeability (Ks).

  • CAEA subjects had 14% lower Ks than controls (p = 0.036).
  • The study included 60 consecutive CAEA subjects and 60 clinically/angiographically matched controls enrolled across three tertiary centers.
  • Multivariable regression analysis showed an association of CAEA with lower Ks (p < 0.05).

Patients with CAEA had reduced susceptibility of fibrin clots to fibrinolysis, shown by longer clot lysis time (CLT).

  • CLT was 25% longer in CAEA subjects than in controls (p = 0.001).
  • Multivariable regression analysis showed an association of CAEA with longer CLT (p < 0.05).

Patients with CAEA had higher levels of the oxidative stress marker 3-nitrotyrosine than controls.

  • 3-nitrotyrosine levels were 21% higher in CAEA subjects (p = 0.002).
  • Multivariable regression analysis showed an association of CAEA with higher 3-nitrotyrosine levels (p < 0.05).

Within CAEA patients, oxidative stress correlated with unfavorable fibrin clot properties.

  • 3-nitrotyrosine levels correlated negatively with Ks (r = -0.31, p = 0.016).
  • 3-nitrotyrosine levels correlated positively with CLT (r = 0.27, p = 0.037).
  • The authors suggest oxidative stress may contribute to unfavorable modification of fibrin clot properties in CAEA.

Greater CAEA size, measured as peak-to-reference diameter ratio, was associated with worse fibrin clot phenotype and greater oxidative stress.

  • With increasing CAEA peak-to-reference diameter ratio, Ks decreased (p-trend = 0.017).
  • 3-nitrotyrosine levels increased with increasing ratio (p-trend = 0.002).

The CAEA cohort was predominantly male and older, and half had concomitant coronary artery disease.

  • 52 of 60 (86.7%) CAEA patients were male.
  • Median age was 66.0 (59.5-74.1) years.
  • 30 (50.0%) had concomitant coronary artery disease.

CAEA is independently associated with unfavorably altered fibrin clot properties.

  • Multivariable regression analyses showed associations of CAEA with lower Ks, longer CLT and higher 3-nitrotyrosine (all p < 0.05).
  • Authors note CAEA are present in up to 5% of patients undergoing coronary angiography and are independently associated with myocardial infarction risk, though mechanisms were unclear.
  • The study is registered as CARE-ANEURYSM, NCT05183373.

What This Means

This study looked at people who have enlarged or bulging sections of their coronary arteries (ectasias and aneurysms), which occur in up to 5% of people having coronary angiography. Earlier research linked these conditions to a higher risk of heart attack, but it was unclear why. The researchers compared blood clot properties in 60 patients with these artery changes and 60 closely matched people without them, at three medical centers. The clots from patients with coronary aneurysms or ectasias were denser (14% less permeable) and took 25% longer to break down than clots from controls. These patients also had 21% higher levels of 3-nitrotyrosine, a marker of oxidative stress. Higher oxidative stress went along with denser clots that dissolved more slowly, and the larger the artery enlargement, the denser the clots and the higher the oxidative stress. This research suggests that the tendency toward heart attack in people with coronary aneurysms may be partly due to blood clots that are harder to break down, possibly influenced by oxidative stress. The study shows association, not proof of cause, and it was fairly small, so further work would be needed to confirm these results and to see whether they could guide treatment.

Have a question about this study?

Citation

Chmiel J, Kopytek M, D&#x105;browski M, Iwa&#x144;czyk S, Musia&#x142; K, Wo&#x17a;niak P, et al.. (2026). Fibrin Clot Properties in Aneurysmal Coronary Artery Disease: CARE-ANEURYSM Study.. International journal of molecular sciences. https://doi.org/10.3390/ijms27209059